NCT06748911 (DS-MCE-BE) is a NA clinical trial of NaviCam Detachable String Capsule in Barrett's Esophagus, sponsored by Mayo Clinic.

Who is sponsoring NCT06748911?

NCT06748911 is sponsored by Mayo Clinic.

What drugs are being tested in NCT06748911?

Interventions in NCT06748911: NaviCam Detachable String Capsule.

What condition does NCT06748911 study?

NCT06748911 studies Barrett's Esophagus.

Is NCT06748911 still recruiting?

NCT06748911 is currently recruiting now. Last updated 3 April 2026.

Last reviewed 2026-04-03 · How we verify

NCT06748911: DS-MCE-BE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Navicam for Detection of Barrett's Esophagus

Recruiting now NA Last updated 3 April 2026

What this trial tests

NA trial testing NaviCam Detachable String Capsule in Barrett's Esophagus in 57 participants. Currently enrolling.

Timeline

20 February 2025

Primary endpoint
30 June 2026

30 June 2026

Quick facts

Lead sponsor	Mayo Clinic
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	57
Start date	20 February 2025
Primary completion	30 June 2026
Estimated completion	30 June 2026
Sites	1 location across United States

Drugs / interventions tested

NaviCam Detachable String Capsule

Conditions studied

Barrett's Esophagus — all drugs for Barrett's Esophagus →

Sponsor

Mayo Clinic

Who can join

22 and older, any sex, with Barrett's Esophagus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Using a non-invasive capsule system to achieve optimal viewing angles of the esophagus for detection of Barrett's esophagus

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Barrett's Esophagus

Currently open trials in the same condition.

NCT05818072 — The Prevalence, Risk Factors and Optimal Biopsy Protocol of BE · NA · recruiting
NCT00590239 — Barrett's Esophagus Related Neoplasia (BERN) Project · recruiting
NCT00288119 — Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma · recruiting

Other Mayo Clinic trials

Trials by the same sponsor.

NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06748911 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
Last refreshed: 3 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06748911.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing